PORTLAND, OR | January 30, 2018 - Cascade AIDS Project (“CAP”) is proud to announce that it has been awarded $100,000 from Gilead Sciences, Inc. to fund HIV prevention navigation and STI testing work.

The program addresses the comprehensive set of projects and activities aimed at reducing cases of HIV and STI cases across the Portland, Oregon metropolitan region. Specifically, the program is comprised of easily accessible HIV/STI testing clinics, connection to treatment and support services for those testing positive, community education both for those testing positive to prevent further spread of infections and prevention education for the wider community, and one on one health education session for high-risk individuals focused on personalized prevention strategies.

“A key component of the HIV Prevention Navigation program is testing – which is a critical way to reduce new cases of HIV and limit spread of the epidemic. There is also a strong focus on helping individuals navigate the complicated systems and processes so they, and their partners, can remain in good health,” said Caitlin Wells, CAP’s Director of Healthcare Operations. “Our hope and expectation is that this program will allow us to keep up our work in the community connecting high-risk individuals to low-barrier testing programs and additional resources to guarantee a population that is thriving.”

The grant will fund CAP’s HIV prevention navigation work for one year.